News About: Pharm. Industry


Mark Timley named new president of MSD Korea

MSD Korea said recently said that it appointed Mark Timley, sales and marketing director of MSD Australia, as new president of MSD Korea. Timley replaced Lee Seung-woo, who had left the presidency two months ago and w...

Bulk drug production items should be diversified.

The industry has concentrated the bulk drug production largely on antibiotics but recently realized it necessary to diversify to other items. According to the KPMA data, the total production value of the top 100 bu...

Foreign multinational drug corporations complained government policies.

Most of foreign multinational drug corporations in presence of Korea are flared up with the recent government's drug pricing slash. Though they are yet on action, an accorded gesture already demonstrated with harsh...

Domestic pharmaceutical firms' advancement toward overseas market mired

Despite the recent brisk movement towards foreign markets in the domestic pharmaceutical industry of Korea's pharmaceutical firms to foreign markets, there are mounting concerns that domestic pharmaceutical makers are...

OTC drug advertising scope must extend to more therapeutic groups.

The pharmaceutical industry claimed that the public advertising controls over the OTC drugs should be eased more to other therapeutic groups in view of saving the NHI finance and boosting more OTC drug consumptions. ...

Strategic tie-up between Samsung venture and KHIPA.

The Korea Health Industry Promotion Agency (Head: Chang Im-won) made a strategic business tie-up with Samsung (President: Kim Sang-gi) bio venture investment company on July 10 for closer and organic cooperation betwe...

Bayer Korea decided to supply OTC products via domestic wholesalers including Zuellig Korea

Bayers Korea said recently it has decided to supply its OTCs, including Aspirin and Carnesten, to all wholesalers as well as Zuellig Korea from July 10. The background of such company decision is that unlike its pr...

Foreign-invested pharmaceutical firms account for 18.2% of drug output

Stimulated by the ongoing system of separating drug dispensing from medical practice, multinational pharmaceutical firms in Korea have continuously witnessed their brisk production activities which may affect ...

Domestic pharmaceutical firms rushing to overseas markets

Korea's leading pharmaceutical firms are rushing to foreign markets in an effort to avoid more cut-throat competition in the already saturated domestic market and expand their positions in the global market via set-up...

Pfizer Korea flamed over employee's surveillance case

The controversy surrounding the recent accident of an assistant manager of Pfizer Korea, who was allegedly shadowed by the company's private detectives, is escalating to a court issue between the management and labor ...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.